by Cell and tissue preservation involves preserving cells and tissues for future use in medical therapies, research and clinical trials. Key factors driving the growth of this market include increasing demand for biobanking, stem cell therapies and organ transplantation. Advances in cell preservation techniques have enabled the storage of cells at ambient and cryogenic temperatures for prolonged durations without compromising cell viability.
Global Cell And Tissue Preservation Market is estimated to be valued at USD 5.11 Bn in 2024 and is expected to reach USD 10.82 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 11.3% from 2024 to 2031.
Key Takeaways
Key players operating in the Global Cell and Tissue Preservation Market are Thermo Fisher Scientific, Inc., Lonza, BD, MerckKGaA, Cytiva, Agilent Technologies, Inc., Avantor, Inc., FUJIFILM Irvine Scientific, BioLifeSolutions Inc., AMSBIO, Princeton CryoTech, STEMCELL Technologies Inc., LGC SeraCare, Corning Incorporated, CellGenix GmbH. Thermo Fisher Scientific is among the leading supplier of medical freezers and cryogenic vials used for cell and tissue preservation.
The growing demand for biobanking is expected to drive the cell and tissue preservation market during the forecast period. With increasing research in fields of regenerative medicines, biobanking helps in collecting, processing and storing biological samples like tissues, cells, blood and genetic materials. This facilitates future use in research insights and translational medicines.
North America and Europe hold a significant share in the overall Global Cell And Tissue Preservation Market Demand due to growing R&D investments. However, Asia Pacific is expected witness fastest growth over the forecast period owing to rising healthcare expenditure, increasing biotech and pharmaceutical research in China and India along with growing medical tourism.
Market Key Trends
One of the key trends in the cell and tissue preservation market is automation of cryogenic specimen storage tanks and introduction of liquid nitrogen free cryopreservation. Automated storage systems such as automated liquid nitrogen storage tanks minimize risks of cross-contamination and improve sample traceability through barcode scanning. Liquid nitrogen free cryopreservation techniques such as use of cryoprotectants and controlled freezing helps in long term storage of samples without dependency on liquid nitrogen. This is an area of ongoing research with potential to disrupt the market.
Porter’s Analysis
Threat of new entrants: The high capital requirements for R&D and manufacturing facilities pose barriers to entry.
Bargaining power of buyers: The presence of multiple alternative products provides bargaining power to buyers.
Bargaining power of suppliers: A few large suppliers of critical raw materials exert bargaining pressure on pricing.
Threat of new substitutes: Continuous innovation in cell preservation methods has increased the threat from new substitutes.
Competitive rivalry: Strong competition exists among the top players to gain market share through product differentiation and portfolio expansion.
Geographical Regions
North America currently dominates the Global Cell and Tissue Preservation Market Regional Analysis , both in terms of value and volume. This is attributed to the increasing demand for stem cell therapy, rise in tissue engineering practices, and growing focus on research activities in the region.
The Asia Pacific region is expected to witness the fastest growth over the forecast period owing to the rising healthcare expenditure, increasing healthcare infrastructure development, and growing awareness about regenerative medicine in countries such as China, India, and Japan.
The global cell and tissue preservation market is highly concentrated in North America, driven by increasing utilization of cell and tissue preservation in biobanking applications, cancer research, and regenerative medicine. The United States accounts for the major share due to strong government funding for advanced research activities involving cell and tissue preservation techniques.
The Asia Pacific region exhibits the fastest growth and is emerging as a lucrative market. Factors such as rising healthcare expenditure, growing stem cell banking industry, increasing stem cell research initiatives, and developing healthcare infrastructure are boosting market expansion in the Asia Pacific region. China, Japan, and India are expected to witness high growth due to growing healthcare awareness and expanding patient population.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
About Author - Vaagisha Singh
Vaagisha brings over three years of expertise as a content editor in the market research domain. Originally a creative writer, she discovered her passion for editing, combining her flair for writing with a meticulous eye for detail. Her ability to craft and refine compelling content makes her an invaluable asset in delivering polished and engaging write-ups. LinkedIn
